Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by DrHolidayon Aug 08, 2018 3:55pm
126 Views
Post# 28429500

RE:Big Buyers stepping in ICO before close

RE:Big Buyers stepping in ICO before closeThe vested interests seem to be aligned with brokers such as Desjardins and National Bank together. They may have been able to accumulate a rather large position for their clients by trading paper back and forth. Trading out at the highs and going short for the downswing enables them to repurchase before news of partnering. I sense with my intuition and based upon all the research we know about Oral Amp B, that we could be near to a deal with a very good partner to take us right through phase 2 and phase 3 in exchange for a percentage of the multi billion dollar market that wiil overtake and replace the injectable version of the drug. This could be very big for a little company like ICO, so for sure I wouldn't want to be caught short especially before a halt pending news of such magnitude.

DOC
<< Previous
Bullboard Posts
Next >>